Navigation Links
Eppendorf Research pro Electronic Pipette, 20-300 uL, 8-channel with charging unit

ProductsEppendorf Research pro Electronic Pipette, 20-300 uL, 8-channel with charging unit
Company Eppendorf North America
Item Eppendorf Research pro Electronic Pipette, 20-300 uL, 8-channel with charging unit
Features 
Description The Research pro Electronic Pipette is ideal for all liquid handling applications in the laboratory. Its easy-to-follow display, ergonomically-placed operating buttons, and various dispensing techniques such as pipetting, dispensing, reverse pipetting and diluting make this a lab favorite. It intuitively handles the simple functions of a manual pipette without any adverse effects on the variety of programs. Additionally, the multichannel version includes all of the single-channel pipette functions, therefore either model can be used with no additional training required.
Info Eppendorf North America
Customer Service: (800) 645-3050
Web site: http://www.eppendorfna.com/home/

Related medicine products :

1. Eppendorf Thermomixer
2. Eppendorf Thermomixer R
3. Eppendorf ThermoStat Plus, without block
4. Eppendorf Refrigerated Multipurpose Centrifuge Model 5804R
5. Eppendorf Refrigerated Multipurpose Centrifuge Model 5810R
6. Eppendorf Heat Sealing Film
7. Eppendorf heat sealing film
8. Eppendorf PCR film, self adhesive
9. Eppendorf Heat Sealing Foil
10. Eppendorf PCR foil, self adhesive
11. Eppendorf Sealing Mat 96
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (
VascoScrew is a low profile unipolar pacing lead with a fixed screw for permanent pacing. Due to latest technologies, VascoScrew 6/60 M is compatible to all pacemaker-cavities with the size of IS-1 (
The VascoTip J 9/60 PU is a unipolar tined, J-preformed permanent pacing lead. Due to advanced technology, VascoTip J 9/60 PU M is compatible to all pacemaker-cavities with the size of IS-1 (3.2 mm),
Medicine Products:
(Date:12/3/2008)...e-USNewswire/ -- In recognition of the value the A...orship, ASH is proud to honor George Buchanan, M.D...s, which highlight the important role mentors play...ematologists early in their careers. , , Ea...f laboratory science and the other from patient-or...
(Date:12/3/2008)...ollege of Technology has extended its military sch...ave served in Iraq or Afghanistan. This scholarshi...d is also available to spouses and dependents of m... Up to $150,000 in scholarships is available for s...ology or Medical Careers Institute, the School of ...
(Date:12/3/2008)...eries were free of tumor recurrence an average of ...nn., Dec. 3 A new Mayo ...iomas survived longest when they underwent aggress...mor. If safely removing the entire tumor was not p...en surgery was followed by radiation therapy. This...
(Date:12/3/2008)... Greater Than Entire U.S. Economy , , DALLA...l government stopped the Medicare and Social Secur...l taxes and allowing no more accrual of benefits -...ho have already earned these benefits, according t...alysis (NCPA). , , "The numbers are stagg...
Breaking Medicine News(10 mins):Health News:Inspirational Hematologists Honored With Mentor Awards From the American Society of Hematology 2Health News: ECPI College of Technology and Medical Careers Institute Announce Extension for South Carolina Military Scholarship Opportunity 2Health News:Mayo Clinic Identifies Best Treatments for Long-Term Survival in Brain Tumor Patients 2Health News:Mayo Clinic Identifies Best Treatments for Long-Term Survival in Brain Tumor Patients 3Health News:Medicare, Social Security Owe Up to $52 Trillion to Current Retirees and Workers 2
...y researchers at Washington University School of M... of a protein that absorbs lipids in the upper par...vide a novel approach for obesity treatment in the.... Nada A. Abumrad, the Dr. Robert C. Atkins Profes...
...sis of five major breast cancer trials has confirm...astuzumab and chemotherapy improves survival in w...At the ESMO Conference Lugano, Issa Dahabreh from ...e results of a meta-analysis of 5 trials involving...
...study,the rogue proteins that cause chronic wastin...ir infectious nature when bound to common soil par... Science (PLoS) Pathogens, a group led by Universi...dd Aiken reports that prions, the protein agents o...
...n people in the US could be suffering from atrial ...atients is forecast to soar. It is a condition i... should. Instead of beating in a regular, normal p...rregularly and too fast.The two small upper chambe...
Other Medicine News:Health News:Protein That Absorbs Lipids may Provide Future Weight-loss Strategies 2Health News:Combination of Tratuzumab and Chemotherapy Yields Better Results for Breast Cancer 2Health News:Prions Capacity can Be Aggrevated by Solid Particles 2Health News:Prions Capacity can Be Aggrevated by Solid Particles 3Health News:Clamor for Catheter-based Ablation Increasing Among Heart Patients in US 2Health News:Clamor for Catheter-based Ablation Increasing Among Heart Patients in US 3
(Date:12/2/2008)...re-USNewswire/ -- Researchers using functional,MR... area of the brain,responsible for suppressing me...stress-related psychiatric disorders. Results of t...eting of the Radiological Society of North America...sion and other stress-related disorders,traumati...
(Date:12/2/2008)...ewswire/ -- Horizon Therapeutics, Inc., a,private... that two pivotal,Phase 3 trials evaluating its l...et all primary endpoints. HZT-501, a novel, propri...buprofen and famotidine, demonstrated a,statistic...-steroidal,anti-inflammatory drug (NSAID)-induced...
(Date:12/1/2008)...wire/ -- TargeGen has announced that an oral,pres...er, US-based clinical,trial of TG101348 in myelop...t,the 2008 American Society of Hematology (ASH) M... as follows:, Title: A Phase I ... JAK2-Selective Inhibitor, in Pati...
(Date:12/1/2008)... the best policy , , ROCHESTER, Minn., Dec...yo Clinic finds the use of the drug therapy etaner...an acute inflammation of the liver caused by exces...udy are published in the December issue of Gastro... , VIDEO ALERT: Additional audio and video r...
Breaking Medicine Technology:Stress-Related Disorders Affect Brain's Processing of Memory 2Stress-Related Disorders Affect Brain's Processing of Memory 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 2Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 3Horizon Therapeutics Announces Two Pivotal HZT-501 Phase 3 Trials Meet Primary Endpoints 4Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 2Mayo Clinic Seeks New Therapies for Alcoholic Hepatitis 3MIT 3A Safe storage of greenhouse gas carbon dioxide 5901 1MIT 3A Safe storage of greenhouse gas carbon dioxide 5901 2U of U researchers to use patients own stem cells to treat heart failure 29955 1U of U researchers to use patients own stem cells to treat heart failure 29955 2Necessary lattes 3F 29953 1Necessary lattes 3F 29953 2Bottoms up 3A Individualists more likely to be problem drinkers 29951 1Bottoms up 3A Individualists more likely to be problem drinkers 29951 2
...A Pharmaceuticals,Inc. (Nasdaq:ACAD) today announc...izophrenia co-therapy trial with ACP-103, ACADIA,s... The trial,evaluated ACP-103 co-therapy when used ...ribed atypical antipsychotic drug, or,haloperidol,...apy,arms with ACP-103 demonstrated statistically s...
.../ -- La Jolla,Pharmaceutical Company today announc... Phase 3 trial of Riquent(R) (abetimus,sodium), it...("lupus" or "SLE"). The updated analyses reinforce...e and significant dose response,between the 100 mg... placebo (p=0.0001). These interim data were initi...
Other Medicine Technology:Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 2Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 3Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 4Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 5Acadia Announces Positive Results From ACP-103 Phase II,Schizophrenia Co-Therapy Trial 6La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 2La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 3La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 4La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 5La Jolla Pharmaceutical Provides Update on Interim Antibody Results,From Riquent Lupus Phase 3 Trial 6